Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Neuromed IRCCS
Age
30–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females between 30 and 70 years of age
Hypertensive patients: Patients with a previous diagnosis of hypertension
Normotensive patients: subjects without story of hypertension
Written informed consent
You may not be if
Severe hypertension (eg, systolic \>180 mm Hg, diastolic \>110 mm Hg)
Manifested or suspected secondary hypertension (coarctation of the aorta, hyperaldosteronism, unilateral or bilateral renal artery stenosis, pheochromocytoma)
Clareo Health | Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects
